ArticleInternational journal of molecular sciences2026
MoDeMol: A Decomposition-Based Evolutionary Framework for Multi-Objective Molecular Optimization.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Lead compound multi-objective optimization requires balancing mutually restrictive drug-like properties, yet conventional latent generative and evolutionary optimization methods suffer from structural-function misalignment, population structural redundancy and low search efficiency under limited evaluation budgets. This work proposes a decomposition-based evolutionary framework built on a score-informed latent space (MoDeMol), with four core innovations: (1) Contrastive fine-tuned Transformer-VAE latent space supervised by predicted dual-target activity scores to improve the alignment between latent spatial proximity and predicted target-activity profiles. (2) Hybrid population initialization combining lead latent perturbation and high-quality molecular bank screening to balance local scaffold retention and global high predicted-activity region exploration. (3) Adaptive resource allocation mechanism for dynamic subproblem computation scheduling to boost optimization efficiency when the property evaluation budget is limited. (4) Dynamic Morgan fingerprint similarity penalization to suppress structural redundancy and maintain diverse molecular scaffolds in the population. Extensive benchmarks on single-target GSK3β and dual-target GSK3β/JNK3 kinase optimization tasks demonstrate that MoDeMol outperforms MolFinder, JANUS and MOMO in success rate, Pareto hypervolume and qualified molecular yield. Quantitative latent-space analyses, qualitative visualization, scaffold tracking, and ablation experiments provide complementary evidence for the contributions of the proposed components. The proposed framework addresses representation alignment, structural redundancy, and search-resource allocation within a computational multi-target lead-optimization workflow under limited evaluation budgets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.